目的 探讨和分析激素吸入治疗对支气管扩张合并支气管哮喘的临床反应性。方法 研究选择2014年7月-2017年7月 间在我院治疗的100例支气管扩张并支气管哮喘患者当做研究对象，依入院顺序分甲组、乙组，每组50例。所有患 者均进行常规治疗，而甲组患者加用激素吸入治疗，评价甲乙两组患者的疗效、肺功能指标、血常规指标。结果 乙组患者治疗的总有效率（91.09%）低于甲组患者（98.02%），差异对比具有统计学意义。甲组患者的用力肺活量 (2.41±0.37)L大于乙组患者(2.08±0.17)L，甲组患者的用力肺活量大于乙组患者，差异对比具有统计学意义。甲 组患者的第1秒用力呼气容积,用力肺活量的占比大于乙组患者，差异对比具有统计学意义。甲组患者的最大呼气流 速峰值大于乙组患者，甲组患者的淋巴细胞水平、中性粒细胞水平、白细胞数水平低于乙组患者，差异对比具有统 计学意义。结论 在支气管扩张并支气管哮喘患者中，激素吸入治疗的效果确切，同时改善了患者的肺功能和血常 规指标，应推广使用。

Objective To investigate the clinical response of bronchiectasis with bronchial asthma to hormone inhalation. Methods 100 cases of bronchiectasis and bronchial asthma patients were selected as the research object from July 2014 to July 2017 in our hospital. They were divided into group A, group B, 50 cases in each group, according to the order of admission. All patients were the routine treatment, while patients in A group added hormone treatment. The curative effect, pulmonary function index and blood routine index of the two groups were evaluated. Results the total efficiency of treatment group B patients (91.09% patients) than group (98.02%), the difference was statistically significant. Compared with the group of patients with FVC (2.41+0.37) L is more than group B patients (2.08+0.17) L, the group of patients with FVC than group B patients, the difference was statistically significant. Compared with the group of patients with FEV1, FVC The proportion is higher than group B, the difference was statistically significant compared. The maximum peak expiratory flow rate in group A is greater than group B patients, the group of patients with lymphocytes, neutrophils, white blood cell count level was lower than that in group B patients, compared with statistical significance. Conclusion For the patients with bronchiectasis and bronchial asthma, inhaled corticosteroid is effective, which improve the patient's lung function and blood routine indexes should be used.